USJ Stock Chart & Stats
€18.40
-€0.40(-1.19%)
At close: 4:00 PM EST
€18.40
-€0.40(-1.19%)
Day’s Range― - ―
52-Week Range€14.10 - €27.20
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€344.90M
Enterprise Value€213.63
Total Cash (Recent Filing)€162.75M
Total Debt (Recent Filing)€14.00M
Price to Earnings (P/E)45.1
Beta0.74
Next Earnings
Aug 04, 2026EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding18,463,010
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.85
Revenue Forecast (FY)€820.87M
Bulls Say, Bears Say
Bulls Say
High Gross Margins And Consumable RevenueA ~77% gross margin on consumable nutrition products indicates durable unit economics and pricing power versus peers. Repeat purchase behavior and autoship-style programs support recurring revenue and margin stability, providing a structural buffer as USANA scales omni-channel and retail footprints.
Conservative, Low-leverage Balance SheetExtremely low debt gives USANA long-term financial flexibility to absorb inventory builds, fund retail rollouts, invest in R&D, and weather cyclical shocks without material refinancing risk. This conservatism supports strategic investments and limits leverage-driven downside.
Omni-channel Expansion And Rise Wellness TractionStrong, repeatable retail distribution (Costco, Target, Walmart) and rapid Rise Wellness growth represent a structural shift from pure direct selling to a diversified omni-channel model. This reduces distributor concentration risk and creates scalable SKU/retail economics if sell-through and margins sustain.
Bears Say
Compressed Profitability And Weak Net MarginsA TTM net margin near 1% signals materially diminished earnings power versus historical levels, reducing returns on equity and internal funding capacity. Structural margin pressure from higher SG&A and customer acquisition could persist until scale benefits and operational efficiencies fully materialize.
Weak Cash Generation And Low Free Cash FlowVery low free cash flow constrains USANA's ability to fund inventory needs, retail expansion, and product development without drawing on reserves or altering capital returns. Sustained low cash conversion raises structural funding risk during multi-channel scaling and inventory cycles.
HYA Early-stage Economics And Elevated Acquisition CostsHYA's growth is capital-intensive: elevated CAC and higher SG&A while expanding internationally and into retail mean the brand may remain margin dilutive for an extended period. Persistent CAC or uneven retail cadence (Costco variability) could delay positive unit economics and press cash needs.
USANA Health News
USJ FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was €14.10 and its highest was €27.20 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is €344.90M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Aug 04, 2026 which is in 8 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on May 05, 2026. The company reported €0.534 earnings per share for the quarter, beating the consensus estimate of €0.386 by €0.149.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.38.
How many shares outstanding does USANA Health have?
USANA Health has 18,463,010 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of €0.534 in its last earnings report, beating expectations of €0.386. Following the earnings report the stock price went up 1.899%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in DE:USJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:USJ Sentiment 100%
Sector Average 63%
Sector Average 63%
Insider Transactions
Sold Shares
Worth €542.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USJ Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful progress across multiple strategic priorities: sequential recovery in the core nutritional business, strong acceleration and retail traction for Rise Wellness, and international and retail expansion for HYA alongside operational integrations and a sizable R&D pipeline. Near-term pressures include higher customer acquisition costs (HYA), increased SG&A, cash used to support initial retail inventory (Costco), and some uncertainty around retailer cadence and macro risks. On balance, the positive operational momentum, reaffirmed guidance ($925M–$1.0B) and advancing omni-channel mix outweigh the contained near-term costs and risks.View all DE:USJ earnings summariesTechnical Analysis
Herbalife
―
Lifeway Foods
―
Nature's Sunshine Products
―
LifeVantage
―
FitLife Brands
―